Micro-Nano formulations

micro nano

Through several years of development of research projects together with relevant Universities, Research Centers and high tech spin offs, we have developed technologies and capabilities for the up scaling of production of nanopharmaceuticals at our GMP facilities allocated in the EU. The proposed technologies, mainly based in lipid matrices, allows the obtaining of nanoformulations of different drugs in a safe and efficient way.

Praxis has developed two Technology Platforms for the Development, Scale-up and Manufacture of Nanomedicines.

We can offer other owned tecnology platforms for the formulation in microparticles. We have a scientific team supporting formulation development activities and process design.

Praxis is member of the ETPN Executive Board. From October 2015. Works as a Chair for the following group: WG Nanotherapeutics & Targeted delivery: Nanotechnologies for Drug Delivery .


Micro-nano formulation

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración, en nuestro enlace Políticas de Seguridad. We use our own cookies and third-party cookies to improve our services and show related advertising to your preferences by analyzing their browsing habits. If you continue to browse, consider accepting its use. You can get more information, or how to change the settings in our Política de privacidad.